+ T细胞,再次证实用不同的制剂进行异源接种可能是一种可行的策略,可以实现长期保护。参考论文Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica,2022, https://doi.org/10.1016/j.virs.2022.11.002 Antonio Bertoletti, Nina Le Bert, Anthony T. Tan, SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic, Immunity, Volume 55, Issue 10, 2022, https://doi.org/10.1016/j.immuni.2022.08.008 Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, Adeline Chia, Nicole Tan, Eng Sing Lee, Edwin Chng, Poh Lian Lim, Barnaby E. Young, David Chien Lye, Nina Le Bert, Antonio Bertoletti, Anthony T. Tan, A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines, Cell Reports Medicine,Volume 3, Issue 11, 2022, 100793,https://doi.org/10.1016/j.xcrm.2022.100793